Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

被引:61
|
作者
Nieuwkerk, Pythia T. [1 ]
Nierman, Melchior C. [2 ]
Vissers, Maud N. [2 ]
Locadia, Mirjam [1 ]
Greggers-Peusch, Philip [2 ]
Knape, Leon P. M. [2 ]
Kastelein, John J. P. [2 ]
Sprangers, Mirjam A. G. [1 ]
de Haes, Hanneke C. [1 ]
Stroes, Erik S. G. [2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 05期
关键词
DISEASE; METAANALYSIS; CHOLESTEROL; STATINS; ILLNESS; TRIALS; ADULTS;
D O I
10.1016/j.amjcard.2012.04.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low levels of statin adherence may compromise treatment outcomes. The aim of this study was to investigate whether nurse-led cardiovascular risk-factor counseling could improve statin adherence and lipid levels without increasing patients' anxiety. Patients with indications for statin therapy for primary or secondary prevention of cardiovascular disease were randomly assigned to receive routine care or extended care (EC) at baseline and at months 3, 9, and 18. Patients in the EC group received a personalized risk-factor passport, showing modifiable and unmodifiable individual risk factors and a graphical presentation of their calculated absolute 10-year cardiovascular disease risk as well as the target risk that could be reached if all modifiable risk factors were optimally treated. Lipid levels were assessed at each visit. Carotid intima-media thickness was measured at baseline and at month 18. Adherence, anxiety, quality of life, symptoms, and smoking status were assessed using a self-administered questionnaire at each visit. A total of 201 patients were included in the study. Statin adherence was significantly higher (p < 0.01) and anxiety was significantly lower (p < 0.01) in the EC group than in the routine care group. Low-density lipoprotein cholesterol was statistically significantly lower in the EC group than in the routine group (2.66 vs 3.00 mmol/L, respectively, p = 0.024) in primary prevention patients only. Intima-media thickness improved significantly from baseline (p < 0.01) in all patients, irrespective of group assignment. In conclusion, cardiovascular risk-factor counseling resulted in improved lipid profiles in primary prevention patients and higher levels of adherence to statins and lower levels of anxiety in all patients. (c) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:666 672)
引用
收藏
页码:666 / 672
页数:7
相关论文
共 50 条
  • [1] Interventions to improve adherence to lipid-lowering medication
    van Driel, Mieke L.
    Morledge, Michael D.
    Ulep, Robin
    Shaffer, Johnathon P.
    Davies, Philippa
    Deichmann, Richard
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (12):
  • [2] A Metaanalysis of Interventions to Improve Adherence to Lipid-Lowering Medication
    Deichmann, Richard E.
    Morledge, Michael D.
    Ulep, Robin
    Shaffer, Johnathon P.
    Davies, Philippa
    van Driel, Mieke L.
    [J]. OCHSNER JOURNAL, 2016, 16 (03): : 230 - 237
  • [3] Cochrane corner: interventions to improve adherence to lipid-lowering medication
    van Driel, Mieke L.
    Morledge, Michael D.
    Ulep, Robin
    Shaffer, Johnathon P.
    Davies, Philippa
    Deichmann, Richard
    [J]. HEART, 2018, 104 (05) : 367 - 369
  • [4] Proactive Pharmaceutical Care Interventions Improve Patients' Adherence to Lipid-Lowering Medication
    Stuurman-Bieze, Ada G. G.
    Hiddink, Eric G.
    van Boven, Job F. M.
    Vegter, Stefan
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1448 - 1456
  • [5] Lipid-lowering medication and risk of cancer
    Olsen, JH
    Johansen, C
    Sorensen, HT
    McLaughlin, JK
    Mellemkjær, L
    Steffensen, FH
    Fraumeni, JF
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (02) : 167 - 169
  • [6] Lipid-lowering medication and risk of injury
    Bovbjerg, VE
    Siscovick, DS
    Psaty, BM
    McCann, BS
    Koepsell, TD
    Raghunathan, TE
    Wagner, EH
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (12) : 1197 - 1200
  • [7] Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
    Desai, Nihar R.
    Farbaniec, Michael
    Karalis, Dean G.
    [J]. CLINICAL CARDIOLOGY, 2023, 46 (01) : 13 - 21
  • [8] Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
    Kratky, Vojtech
    Valerianova, Anna
    Hruskova, Zdenka
    Tesar, Vladimir
    Malik, Jan
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (04) : 103 - 109
  • [9] Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
    Vojtech Kratky
    Anna Valerianova
    Zdenka Hruskova
    Vladimir Tesar
    Jan Malik
    [J]. Current Atherosclerosis Reports, 2024, 26 : 103 - 109
  • [10] INTERVENTIONS TO IMPROVE ADHERENCE TO LIPID LOWERING MEDICATION
    Morledge, Michael
    Ulep, Robin
    Shaffer, Johnathon
    van Driel, Mieke
    Deichmann, Richard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1954 - 1954